The US Food and Drug Administration (FDA) has awarded a Breakthrough Device Designation to Neuralink’s latest brain implant device, Blindsight. This...
Vous n'êtes pas connecté
Elon Musk’s company, Neuralink, has reached a major milestone with its brain chip. The device, called “Blindsight,” is designed to help blind people regain their vision. Neuralink announced that the U.S. Food and Drug Administration (FDA) has given the implant a special status known as “breakthrough device.” This status allows it to join a program […]
The US Food and Drug Administration (FDA) has awarded a Breakthrough Device Designation to Neuralink’s latest brain implant device, Blindsight. This...
The US Food and Drug Administration (FDA) has awarded a Breakthrough Device Designation to Neuralink’s latest brain implant device, Blindsight. This...
Highlights: Neuralink's Blindsight implant sends visual information directly to the brain, bypassing damaged optic
Neuralink announced this morning that they have received FDA approval to test a new implant that will allow blind people to see again. The Blindsight...
Neuralink announced this morning that they have received FDA approval to test a new implant that will allow blind people to see again. The Blindsight...
Elon Musk says device will restore people?s sight.
Neuralink's Blindsight implant aims to restore vision for individuals with complete blindness by bypassing damaged optic nerves and directly...
The US FDA has approved Bristol Myers Squibb’s oral medicine, Cobenfy, for treating schizophrenia in adults. This is the first new type of...
THURSDAY, Sept. 26, 2024 -- The U.S. Food and Drug Administration has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) as the first and...
Brussels (Belgium), September 23, 2024 – 07:00 (CEST) – UCB, a global biopharmaceutical company, announced today that the U.S. Food and...